Annual balance sheet for Replimune, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 396 | 583 | 421 | 484 | 269 |
| Net Total Receivables | 3.06 | 2.94 | 4.92 | 3.73 | 1.62 |
| Prepaid Expenses | |||||
| Total Current Assets | 404 | 593 | 434 | 496 | 279 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 55.6 | 52.4 | 52.4 | 52.5 | 48.6 |
| Other Long Term Assets | |||||
| Total Assets | 461 | 647 | 488 | 551 | 332 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20.8 | 33.8 | 40.4 | 62.4 | 58.2 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 50 | 91.3 | 113 | 135 | 166 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 411 | 555 | 375 | 416 | 166 |
| Total Liabilities & Shareholders' Equity | 461 | 647 | 488 | 551 | 332 |
| Total Common Shares Outstanding |